These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29981039)

  • 21. A cost-benefit/cost-effectiveness analysis of proposed supervised injection facilities in Ottawa, Canada.
    Jozaghi E; Reid AA; Andresen MA; Juneau A
    Subst Abuse Treat Prev Policy; 2014 Aug; 9():31. PubMed ID: 25091704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
    Strike C; Watson TM
    Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia.
    Salmon AM; van Beek I; Amin J; Kaldor J; Maher L
    Addiction; 2010 Apr; 105(4):676-83. PubMed ID: 20148794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Support of supervised injection facilities by emergency physicians in Canada.
    Katz N; Leonard L; Wiesenfeld L; Perry JJ; Thiruganasambandamoorthy V; Calder L
    Int J Drug Policy; 2017 Nov; 49():26-31. PubMed ID: 28886562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The willingness of people who inject drugs in Boston to use a supervised injection facility.
    León C; Cardoso L; Mackin S; Bock B; Gaeta JM
    Subst Abus; 2018 Jan; 39(1):95-101. PubMed ID: 28799847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a medically supervised injection facility among street youth.
    Hadland SE; DeBeck K; Kerr T; Nguyen P; Simo A; Montaner JS; Wood E
    J Adolesc Health; 2014 Nov; 55(5):684-9. PubMed ID: 24925493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
    Kerr T; Small W; Moore D; Wood E
    Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using drugs in un/safe spaces: Impact of perceived illegality on an underground supervised injecting facility in the United States.
    Davidson PJ; Lopez AM; Kral AH
    Int J Drug Policy; 2018 Mar; 53():37-44. PubMed ID: 29278831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.
    Hood JE; Behrends CN; Irwin A; Schackman BR; Chan D; Hartfield K; Hess J; Banta-Green C; Whiteside L; Finegood B; Duchin J
    Int J Drug Policy; 2019 May; 67():9-18. PubMed ID: 30802842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
    Wallace B; Pagan F; Pauly BB
    Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Examining Overdose and Homelessness as Predictors of Willingness to Use Supervised Injection Facilities by Services Provided Among Persons Who Inject Drugs.
    Kenney SR; Anderson BJ; Bailey GL; Herman DS; Conti MT; Stein MD
    Am J Addict; 2021 Jan; 30(1):21-25. PubMed ID: 32519449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study.
    Bouvier BA; Elston B; Hadland SE; Green TC; Marshall BD
    Harm Reduct J; 2017 Feb; 14(1):13. PubMed ID: 28219388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rigidity, dyskinesia and other atypical overdose presentations observed at a supervised injection site, Vancouver, Canada.
    Kinshella MW; Gauthier T; Lysyshyn M
    Harm Reduct J; 2018 Dec; 15(1):64. PubMed ID: 30577844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acceptability of supervised injection facilities among persons who inject drugs in upstate New York.
    Duncan E; Shufelt S; Barranco M; Udo T
    Harm Reduct J; 2022 Jul; 19(1):87. PubMed ID: 35907854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug consumption rooms: A systematic review of evaluation methodologies.
    Belackova V; Salmon AM; Day CA; Ritter A; Shanahan M; Hedrich D; Kerr T; Jauncey M
    Drug Alcohol Rev; 2019 May; 38(4):406-422. PubMed ID: 30938025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An emergency response to the opioid overdose crisis in Canada: a regulated opioid distribution program.
    Tyndall M
    CMAJ; 2018 Jan; 190(2):E35-E36. PubMed ID: 29335260
    [No Abstract]   [Full Text] [Related]  

  • 37. Supervised injection services: what has been demonstrated? A systematic literature review.
    Potier C; Laprévote V; Dubois-Arber F; Cottencin O; Rolland B
    Drug Alcohol Depend; 2014 Dec; 145():48-68. PubMed ID: 25456324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of COVID-19 public health measures on attendance and overdose at supervised injecting facilities in Australia.
    Roxburgh A; Livingston M; Dietze P; Nielsen S; Cogger S; Bartlett M; Day C; Latimer J; Jauncey M; Clark N
    Public Health; 2023 Nov; 224():90-97. PubMed ID: 37742585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Science versus politics: the need for supervised injection facilities in Montreal, Canada.
    Jozaghi E
    Int J Drug Policy; 2012 Sep; 23(5):420-1. PubMed ID: 22818890
    [No Abstract]   [Full Text] [Related]  

  • 40. Potential role of safer injection facilities in reducing HIV and hepatitis C infections and overdose mortality in the United States.
    Semaan S; Fleming P; Worrell C; Stolp H; Baack B; Miller M
    Drug Alcohol Depend; 2011 Nov; 118(2-3):100-10. PubMed ID: 21515001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.